ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q3SCImago #12,015Hybrid

Cancer Investigation

Acronym:lcnv
•
Abbreviation (ISO):CANCER INVEST
•
Identifier (ISSN):0735-7907(Print)/1532-4192(Online)
•
Publisher:Informa Healthcare
Clarivate IF (2026)
2.2↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Investigation

WoS Q3
12342.0520181.9620192.420202.1820212.3720222.420231.820241.920252.22026
Annual Impact Factor Metric
Current (2026):2.2
Scopus SJR & RankScopus Q3
0.495
#12,015

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
97

97 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
102articles/year
6.7% Gold OA•77.94% Original Research

Aims & Scope

Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.

Topics Covered (Recognized by AI)
Medicine98.6%Biology91.8%Internal medicine86.3%Genetics85.4%Cancer60.2%Chemistry53.8%Pathology51.1%Biochemistry45%Surgery40.9%Oncology40.3%Cancer research39.1%Immunology33.6%Chemotherapy25.8%Gene25%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q3
Rank228/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank249/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.2
Articles / Year67
Total Citations9
2025
IF1.9
Articles / Year92
Total Citations139
2024
IF1.8
Articles / Year73
Total Citations306
2023
IF2.4
Articles / Year67
Total Citations281
2022
IF2.368
Articles / Year73
Total Citations588

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,015Scopus Q3SCImago Profile
Scopus Coverage:1983-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.495

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.90

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,986 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations406
3-Year Documents243
Citable Documents216

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q3
OncologyQ3
Cancer ResearchQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Investigation (acronym: lcnv, abbr: CANCER INVEST, ISSN: 0735-7907) is a peer-reviewed international scholarly journal in the field of Medicine, published by Informa Healthcare in United States since 1983. The periodical holds a Journal Impact Factor (JIF) of 2.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.495 (Q3), an H-index of 97.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 102 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,986 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Informa Healthcare
Publication Language
English
Frequency
Bimonthly
Founding Year
1983
Indexing & Databases
SCIEScopusPubMed
Editorial Address
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: cec67236-fce9-4a26-a309-6bc42d27341b
Database Updated: 2026-10-01